SK3 channel trafficking in endothelial cells
内皮细胞中的 SK3 通道运输
基本信息
- 批准号:10275918
- 负责人:
- 金额:$ 63.6万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-07-01 至 2025-04-30
- 项目状态:未结题
- 来源:
- 关键词:ArteriesAttenuatedBiotinylationBloodBlood PressureBlood VesselsCalciumCardiovascular DiseasesCell LineCell membraneCellsDataElectrophysiology (science)Endothelial CellsFluorescence Resonance Energy TransferFunctional disorderGenesGeneticHumanHypertensionImageImmunofluorescence ImmunologicIon ChannelKnockout MiceMediatingMembrane PotentialsMembrane ProteinsMethodsMicroscopyModelingMusMutationMyographyPathologicPathway interactionsPatientsPhysiologicalPotassiumProbabilityProcessProteinsRNA InterferenceResolutionSignal TransductionStimulusSurfaceSystemic blood pressureSystemic hypertensionTRP channelTelemetryTestingTransgenic MiceUrineVanilloidVasodilationVasodilator AgentsWestern Blottingfamilial hypertensionfluvastatininhibitor/antagonistmouse modelmutantnovelpatch clamprab GTP-Binding Proteinsreceptorstemtraffickingvasoconstriction
项目摘要
Project Summary
Endothelial cells line the wall of all blood vessels and regulate a wide variety of functions, including contractility
and systemic blood pressure. Endothelial cell dysfunction is a hallmark of several cardiovascular diseases, but
pathological mechanisms involved are unclear. Endothelial cells express small-conductance calcium-activated
potassium (SK3) channels, which regulate contractility. Currents (I) generated by SK3 channels in endothelial
cells is the product of the number of channels (N), their open probability (PO) and amplitude (i), such that
I=N.PO.i. Previous studies have focused on identifying mechanisms that regulate the activity of surface SK
channels in endothelial cells. In contrast, mechanisms that control the number (N) of surface SK3 channels in
endothelial cells are poorly understood. Importantly, it is unclear whether physiological stimuli regulate the
abundance of surface SK3 channels to alter arterial contractility. Similarly uncertain is if pathological alterations
in the control of surface SK3 channel abundance occurs during hypertension, leading to attenuated
vasodilation. Using a wide variety of approaches, we provide evidence that vasodilator stimuli activate
trafficking mechanisms that rapidly increase surface SK3 channel abundance in endothelial cells to induce
vasodilation. Preliminary data also suggest that SK3 channel trafficking is dysfunctional during hypertension,
which attenuates this vasodilatory signaling mechanism. In this proposal, we will investigate three specific
aims. Aim 1 will investigate signaling mechanisms by which physiological stimuli alter the surface abundance
of SK3 channels and examine their functional significance. Aim 2 will examine trafficking mechanisms that
control surface SK3 channels in endothelial cells to modify arterial contractility. Aim 3 will study the hypothesis
that hypertension is associated with pathological alterations in SK3 channel trafficking in endothelial cells that
inhibit vasodilation by these proteins. Methods used will include biotinylation, Western blotting, FRET, RNAi,
co-IP, immunofluorescence, super-resolution microscopy, patch-clamp electrophysiology, membrane potential
recording, intracellular Ca2+ imaging, arterial myography, blood pressure telemetry and transgenic mice. This
project will provide significant novel information concerning vasoregulation by SK3 channel trafficking in
endothelial cells.
项目总结
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jonathan H Jaggar其他文献
Jonathan H Jaggar的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jonathan H Jaggar', 18)}}的其他基金
Blood pressure regulation by smooth muscle cell ion channels
平滑肌细胞离子通道调节血压
- 批准号:
9912820 - 财政年份:2017
- 资助金额:
$ 63.6万 - 项目类别:
Blood pressure regulation by smooth muscle cell ion channels
平滑肌细胞离子通道调节血压
- 批准号:
9310737 - 财政年份:2017
- 资助金额:
$ 63.6万 - 项目类别:
相似海外基金
A platform for rapidly generating live attenuated enterovirus vaccines
快速生成减毒肠道病毒活疫苗的平台
- 批准号:
24K02286 - 财政年份:2024
- 资助金额:
$ 63.6万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
I-Corps: Translation potential of an efficient method to generate live-attenuated and replication-defective DNA viruses for vaccine development
I-Corps:一种有效方法的转化潜力,可生成用于疫苗开发的减毒活病毒和复制缺陷型 DNA 病毒
- 批准号:
2420924 - 财政年份:2024
- 资助金额:
$ 63.6万 - 项目类别:
Standard Grant
Developing a robust native extracellular matrix to improve islet function with attenuated immunogenicity for transplantation
开发强大的天然细胞外基质,以改善胰岛功能,并减弱移植的免疫原性
- 批准号:
10596047 - 财政年份:2023
- 资助金额:
$ 63.6万 - 项目类别:
Live attenuated non-transmissible (LANT) Klebsiella pneumoniae vaccines
肺炎克雷伯氏菌减毒非传染性 (LANT) 活疫苗
- 批准号:
10742028 - 财政年份:2023
- 资助金额:
$ 63.6万 - 项目类别:
Protecting Pigs From Enzootic Pneumonia: Rational Design Of Safe Attenuated Vaccines.
保护猪免受地方性肺炎:安全减毒疫苗的合理设计。
- 批准号:
BB/X017540/1 - 财政年份:2023
- 资助金额:
$ 63.6万 - 项目类别:
Research Grant
A “Goldilocks” live attenuated poultry vaccine for Infectious Coryza
用于传染性鼻炎的“Goldilocks”家禽减毒活疫苗
- 批准号:
LP210301365 - 财政年份:2023
- 资助金额:
$ 63.6万 - 项目类别:
Linkage Projects
A novel live-attenuated Zika vaccine with a modified 5'UTR
一种带有改良 5UTR 的新型寨卡减毒活疫苗
- 批准号:
10730832 - 财政年份:2023
- 资助金额:
$ 63.6万 - 项目类别:
Combating melanoma with an attenuated bacterial therapeutic
用减毒细菌疗法对抗黑色素瘤
- 批准号:
10659841 - 财政年份:2023
- 资助金额:
$ 63.6万 - 项目类别:
Investigating Host and Viral Factors for Improved Design of Future Live Attenuated Vaccines for IBV
研究宿主和病毒因素以改进未来 IBV 减毒活疫苗的设计
- 批准号:
BB/V016067/1 - 财政年份:2022
- 资助金额:
$ 63.6万 - 项目类别:
Research Grant
L2M NSERC-Bioengineering attenuated Sclerotinia sclerotiorum strains as bioherbicide for cereal production and lawn management
L2M NSERC-生物工程减毒核盘菌菌株作为谷物生产和草坪管理的生物除草剂
- 批准号:
576545-2022 - 财政年份:2022
- 资助金额:
$ 63.6万 - 项目类别:
Idea to Innovation